← Leaderboards
Victor Cee
Suvalent Therapeutics, Inc.
$532,759
Attributed
$532,759
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2018–19$500K$375K$250K$125K$0
'18
'19
Funding mix
By agency
NIH$532,759 · 2
By mechanism
R43$532,759 · 2
Top collaborators
No co-investigators on record.
Most similar at Suvalent Therapeutics, Inc.
Same institution · by research overlap
- Shawn Xiaohu Ouyang$1,997,648
- Jim Wu$224,999
Others in their field
Other Emerging Leaders on “Anti-Tumor Immune Response”
- Crystal Mackall · Children'S Hosp Of Philadelphia$8,362,873
- Gary Fanger · Rise Therapeutics, Llc$7,793,544
- Nicholas Arpaia · Columbia Univ New York Morningside$7,790,111
- Zachary Scott Morris · University Of Wisconsin-Madison$6,871,026
- Kian H Lim · Washington University$4,040,151
- Sana D Karam · University Of Colorado Denver$3,856,392
Research focus
Anti-Tumor Immune ResponseBaseBindingBinding SitesBioavailableBiological AvailabilityCancer CellCancer TherapyCellsCellular AssayChemical SynthesisC-Myc GenesColon Cancer Cell LineColorectal CancerColorectal Cancer TreatmentComplexCrystallizationDesignDrug DesignDrug KineticsDrug MetabolismEnzyme Inhibitor DrugsEnzymesAnticancer Research